Bone Quality and Fractures in Women With Osteoporosis Treated With Bisphosphonates for 1 to 14 Years
ABSTRACT Oral bisphosphonates are the primary medication for osteoporosis, but concerns exist regarding potential bone‐quality changes or low‐energy fractures. This cross‐sectional study used artificial intelligence methods to analyze relationships among bisphosphonate treatment duration, a wide var...
Guardado en:
Autores principales: | Hartmut H Malluche, Jin Chen, Florence Lima, Lucas J Liu, Marie‐Claude Monier‐Faugere, David Pienkowski |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2ff53bce97bc4583bf673f5e0fb21c29 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Understanding and Managing Corticosteroid-Induced Osteoporosis
por: Kobza AO, et al.
Publicado: (2021) -
Pore‐Size Distribution and Frequency‐Dependent Attenuation in Human Cortical Tibia Bone Discriminate Fragility Fractures in Postmenopausal Women With Low Bone Mineral Density
por: Gabriele Armbrecht, et al.
Publicado: (2021) -
Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment Goals
por: Felicia Cosman, et al.
Publicado: (2021) -
Health‐related quality of life outcomes after surgical treatment of atypical femur fractures: a multicenter retrospective cohort study
por: Jonathon Spanyer, et al.
Publicado: (2021) -
Comparative assessment of fracture risk among osteoporosis and osteopenia patients: a cross-sectional study
por: Tomasevic-Todorovic S, et al.
Publicado: (2018)